BRISTOL MYERS SQUIBB CO Non-operating Income/Expense 2007-2026 | BMY
Beta
What is BRISTOL MYERS SQUIBB CO's current non-operating income/expense?
BRISTOL MYERS SQUIBB CO (BMY) annual non-operating income/expense for 2025 was $-674.0M, a 24.52% increase from 2024. BRISTOL MYERS SQUIBB CO non-operating income/expense for the quarter ending March 31, 2026 was $-32.0M.
What was BRISTOL MYERS SQUIBB CO's non-operating income/expense in 2024?
BRISTOL MYERS SQUIBB CO annual non-operating income/expense for 2024 was $-893.0M, a 177.12% decline from 2023.
What was BRISTOL MYERS SQUIBB CO's non-operating income/expense in 2023?
BRISTOL MYERS SQUIBB CO annual non-operating income/expense for 2023 was $1.16B, a 301.04% increase from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$2.31B
→
FY2025
$-674.0M
07080910111213141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-674.0M | +24.5% | 10-K |
| FY2024 | $-893.0M | -177.1% | 10-K |
| FY2023 | $1.16B | +301.0% | 10-K |
| FY2022 | $-576.0M | -180.0% | 10-K |
| FY2021 | $720.0M | -68.9% | 10-K |
| FY2020 | $2.31B | +346.7% | 10-K |
| FY2019 | $-938.0M | -209.8% | 10-K |
| FY2018 | $854.0M | -49.3% | 10-K |
| FY2017 | $1.69B | +16.4% | 10-K |
| FY2016 | $1.45B | +674.3% | 10-K |
| FY2015 | $187.0M | +189.0% | 10-K |
| FY2014 | $-210.0M | -2.4% | 10-K |
| FY2013 | $-205.0M | -356.3% | 10-K |
| FY2012 | $80.0M | -76.0% | 10-K |
| FY2011 | $334.0M | +259.1% | 10-K |
| FY2010 | $93.0M | -75.6% | 10-K |
| FY2009 | $381.0M | +1831.8% | 10-K |
| FY2008 | $-22.0M | +71.4% | 10-K |
| FY2007 | $-77.0M | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →